Mechanisms Underlying Improved Health Span on a Short-Term Ketogenic Diet

短期生酮饮食改善健康寿命的机制

基本信息

  • 批准号:
    10153626
  • 负责人:
  • 金额:
    $ 36.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-15 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

Summary — Project 3 Mechanisms Underlying Improved Health Span on a Short Term Ketogenic Diet A decrease in mitochondrial mass and function in muscle and neurodegeneration are common complications of aging. Both of these conditions are linked to a decline in physical activity. Even though muscle and brain function are essential to health and quality of life, the molecular chain of events that lead to these devastating conditions and interventions, outside of life long exercise, that slow them remain poorly understood. We have recently shown that a long term ketogenic diet can prevent age-associated loss of muscle and brain function. Since strict diets, like exercise programs, are difficult to maintain throughout life, this study aims to determine whether a short term intervention started late in life is equivalent to the longer term treatment and determine the mechanism underlying the benefits so that novel, less arduous, interventions can be developed to improve the longevity and quality of life in millions of Americans. Specifically, we will look at the role played by acetylation in the effects of a ketogenic diet on mitochondrial mass in muscle and the kynurenine amino transferases (KATs) in the development of neurocognitive decline with age and Alzheimer's disease. Since interventions that improve muscle mitochondrial function improve brain function, the objective of this work is to determine whether a ketogenic diet increases enzymes that prevent a neurotoxin from reaching the brain. Building on previously published research in this area, and strong preliminary data, we have developed the working hypothesis that a ketosis shifts metabolism in a manner similar to exercise resulting in enhanced muscle mitochondrial function and an increase in KATs, enzymes that decrease the amounts of the neurotoxin quinolinic acid in the brain and slow neurodegeneration with age or Alzheimer's disease. We will test this hypothesis by completing these three specific aims: 1) Determine whether ketosis can mimic exercise and reverse the age-related impairments in muscle and brain function; 2) Determine whether an increase in KAT in muscle as a result of ketosis is required and sufficient for the improvement in brain function; and 3) Determine whether increasing acetylation and KAT in muscle can improve learning, memory, and motor function in mice with Alzheimer's disease. This highly innovative proposal explores the molecular mechanism underlying an essential question in aging biology using a completely novel approach where diet is used to prevent hallmarks of aging. The significance of this research is three-fold: 1) It will contribute to a basic understanding of the molecular events leading to age-associated loss of muscle and brain function; 2) It will validate a simple nutritional strategy to improve muscle and brain with aging and thus improve quality of life and reduce mortality in the population; and 3) It will provide a novel molecular target for the development of drugs to slow the progress of Alzheimer's disease. Successful completion of this application is one step towards the long-term objective of our laboratory: to increase quality of life through improved muscle and brain function.
Summary - Project 3 Mechanisms Underlying Improved Health Span on a Short Term Ketogenic Diet A decrease in mitochondrial mass and function in muscle and neurodegeneration are common complications of aging. Both of these conditions are linked to a decline in physical activity. Even though muscle and brain function are essential to health and quality of life, the molecular chain of events that lead to these devastating conditions and interventions, outside of life long exercise, that slow them remain poorly understood. We have recently shown that a long term ketogenic diet can prevent age-associated loss of muscle and brain function. Since strict diets, like exercise programs, are difficult to maintain throughout life, this study aims to determine whether a short term intervention started late in life is equivalent to the longer term treatment and determine the mechanism underlying the benefits so that novel, less arduous, interventions can be developed to improve the longevity and quality of life in millions of Americans. Specifically, we will look at the role played by acetylation in the effects of a ketogenic diet on mitochondrial mass in muscle and the kynurenine amino transferases (KATs) in the development of neurocognitive decline with age and Alzheimer's disease. Since interventions that improve muscle mitochondrial function improve brain function, the objective of this work is to determine whether a ketogenic diet increases enzymes that prevent a neurotoxin from reaching the brain. Building on previously published research in this area, and strong preliminary data, we have developed the working hypothesis that a ketosis shifts metabolism in a manner similar to exercise resulting in enhanced muscle mitochondrial function and an increase in KATs, enzymes that decrease the amounts of the neurotoxin quinolinic acid in the brain and slow neurodegeneration with age or Alzheimer's disease. We will test this hypothesis by completing these three specific aims: 1) Determine whether ketosis can mimic exercise and reverse the age-related impairments in muscle and brain function; 2) Determine whether an increase in KAT in muscle as a result of ketosis is required and sufficient for the improvement in brain function; and 3) Determine whether increasing acetylation and KAT in muscle can improve learning, memory, and motor function in mice with Alzheimer's disease. This highly innovative proposal explores the molecular mechanism underlying an essential question in aging biology using a completely novel approach where diet is used to prevent hallmarks of aging. The significance of this research is three-fold: 1) It will contribute to a basic understanding of the molecular events leading to age-associated loss of muscle and brain function; 2) It will validate a simple nutritional strategy to improve muscle and brain with aging and thus improve quality of life and reduce mortality in the population; and 3) It will provide a novel molecular target for the development of drugs to slow the progress of Alzheimer's disease. Successful completion of this application is one step towards the long-term objective of our laboratory: to increase quality of life through improved muscle and brain function.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Keith Baar其他文献

Keith Baar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Keith Baar', 18)}}的其他基金

University of California Davis Advancing Diversity in Aging Research Scholars Program
加州大学戴维斯分校推进老龄化研究学者计划的多样性
  • 批准号:
    10238776
  • 财政年份:
    2020
  • 资助金额:
    $ 36.45万
  • 项目类别:
University of California Davis Advancing Diversity in Aging Research Scholars Program
加州大学戴维斯分校推进老龄化研究学者计划的多样性
  • 批准号:
    10435495
  • 财政年份:
    2020
  • 资助金额:
    $ 36.45万
  • 项目类别:
University of California Davis Advancing Diversity in Aging Research Scholars Program
加州大学戴维斯分校推进老龄化研究学者计划的多样性
  • 批准号:
    10684027
  • 财政年份:
    2020
  • 资助金额:
    $ 36.45万
  • 项目类别:
Mechanisms Underlying Improved Health Span on a Short-Term Ketogenic Diet
短期生酮饮食改善健康寿命的机制
  • 批准号:
    10398864
  • 财政年份:
    2019
  • 资助金额:
    $ 36.45万
  • 项目类别:
Mechanisms Underlying Improved Health Span on a Short-Term Ketogenic Diet
短期生酮饮食改善健康寿命的机制
  • 批准号:
    10685461
  • 财政年份:
    2019
  • 资助金额:
    $ 36.45万
  • 项目类别:
MoTrPAC: UC Preclinical Animal Study Site
MoTrPAC:UC 临床前动物研究中心
  • 批准号:
    9517521
  • 财政年份:
    2016
  • 资助金额:
    $ 36.45万
  • 项目类别:
MoTrPAC: UC Preclinical Animal Study Site
MoTrPAC:UC 临床前动物研究中心
  • 批准号:
    9246756
  • 财政年份:
    2016
  • 资助金额:
    $ 36.45万
  • 项目类别:
LAT1 and the development of anabolic resistance
LAT1 和合成代谢抵抗的发展
  • 批准号:
    9295905
  • 财政年份:
    2014
  • 资助金额:
    $ 36.45万
  • 项目类别:
LAT1 and the development of anabolic resistance
LAT1 和合成代谢抵抗的发展
  • 批准号:
    9122262
  • 财政年份:
    2014
  • 资助金额:
    $ 36.45万
  • 项目类别:
LAT1 and the development of anabolic resistance
LAT1 和合成代谢抵抗的发展
  • 批准号:
    9052680
  • 财政年份:
    2014
  • 资助金额:
    $ 36.45万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 36.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了